SignalEU/UK

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation

Barclays initiates Ligand Pharma Outperform citing biopharma royalty aggregation catalyst.

What changed

Barclays initiates Ligand Pharma Outperform citing biopharma royalty aggregation catalyst.

Why it matters

Barclays initiates Ligand Pharma Outperform citing biopharma royalty aggregation catalyst. — impact context not separately stored; see What changed.

Sources